What Better Long-Term Recovery After an RTA Could Look Like

The TPS Journaling Space — March 2026 What Better Long-Term Recovery After an RTA Could Look Like For many Road Traffic Accident survivors, recovery does not end when treatment slows down or formal appointments come to an end. Long-term recovery often becomes more complicated after discharge — when people are trying to manage pain, fatigue,Continue reading “What Better Long-Term Recovery After an RTA Could Look Like”

Why Recovery Needs Structure, Not Just Support

The TPS Journaling Space — March 2026 Why Recovery Needs Structure, Not Just Support Support matters deeply in long-term recovery after a Road Traffic Accident. But support on its own is not always enough. Many survivors receive help in parts and still find themselves struggling — because what is missing is not simply care, butContinue reading “Why Recovery Needs Structure, Not Just Support”

The Insurer’s Dilemma: Why Cost-Controlled Pathways Produce the Long-Tail Costs They’re Designed to Avoid

The TPS Journaling Space — February 2026 The Insurer’s Dilemma: Why Cost-Controlled Pathways Produce the Long-Tail Costs They’re Designed to Avoid “Why short-term cost control can unintentionally produce the longer-term costs a pathway was meant to avoid.” 01 The structural tension One of the least acknowledged tensions in long-term RTA recovery is this: pathways designedContinue reading “The Insurer’s Dilemma: Why Cost-Controlled Pathways Produce the Long-Tail Costs They’re Designed to Avoid”

Identity After an RTA: The Recovery Dimension That Sits Between the Clinical Pathway and the Legal Claim

The TPS Journaling Space — February 2026 Identity After an RTA: The Recovery Dimension That Sits Between the Clinical Pathway and the Legal Claim “The recovery dimension that is often left unheld.” 01 The quiet disruption Long-term recovery after an RTA is not only about pain, mobility, or physical function. It can also involve aContinue reading “Identity After an RTA: The Recovery Dimension That Sits Between the Clinical Pathway and the Legal Claim”